Allergan, Inc. News Headlines

AGN 
$212.63
*  
0.45
0.21%
Get AGN Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Bayer Discloses Encouraging Data on Anticoagulant Xarelto - Analyst Blog
9/3/2014 4:10:00 PM - Zacks.com


Misleading Statements In The Ruane, Cunniff, Goldfarb Annual Meeting Transcript Regarding Valeant And Allergan
9/3/2014 12:29:00 PM - Seeking Alpha


AstraZeneca Reports Data on Brilinta from ATLANTIC Study - Analyst Blog
9/2/2014 5:40:00 PM - Zacks.com


Bayer/Johnson & Johnson to Expand Xarelto Label Further - Analyst Blog
9/2/2014 5:30:00 PM - Zacks.com


Novartis Releases Positive Data on LCZ696 for Heart Failure - Analyst Blog
9/2/2014 4:10:00 PM - Zacks.com


UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog
9/2/2014 3:45:00 PM - Zacks.com


Prestige Brands to Sell Bonine for Insight Acquisition - Analyst Blog
9/2/2014 3:35:00 PM - Zacks.com


Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes - Analyst Blog
9/2/2014 2:00:00 PM - Zacks.com


Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog
9/2/2014 1:50:00 PM - Zacks.com


TSX Plunges Deeper Into the Red, Down 44 Points Mid-Afternoon, As Resource Stocks Continue to Decline
9/2/2014 1:15:59 PM - MT Newswires


TSX Down 21 Points at Midday As Resource Stocks Drag, But Healthcare Rally Limits Drop
9/2/2014 11:15:20 AM - MT Newswires


Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned - Analyst Blog
8/29/2014 3:30:00 PM - Zacks.com


Walgreens-AK Health Department Unite to Curb Whooping Cough - Analyst Blog
8/29/2014 2:00:00 PM - Zacks.com


RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog
8/28/2014 5:40:00 PM - Zacks.com


Allergan Seeks Court Order to Stop Valeant, Affiliates - Analyst Blog
8/28/2014 3:40:00 PM - Zacks.com


3 Questions for Allergan Inc.
8/27/2014 1:54:44 PM - Motley Fool


Cardiome Pharma Signs Agreement with Eurolab for Brinavess - Analyst Blog
8/26/2014 5:26:00 PM - Zacks.com


Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog
8/26/2014 5:22:00 PM - Zacks.com


John Paulson's Big Q2 Buys
8/26/2014 10:39:00 AM - Seeking Alpha


How Valeant Continues To Hide Important Financial Data From Investors That Other Pharmas Disclose
8/26/2014 9:39:00 AM - Seeking Alpha


ViiV Healthcare's Single-Pill HIV Drug Triumeq Cleared by FDA - Analyst Blog
8/25/2014 3:30:00 PM - Zacks.com


Roche to Boost Respiratory Product Lineup with InterMune Buy - Analyst Blog
8/25/2014 2:03:00 PM - Zacks.com


In the news: Burger King looks North, Roche to buy InterMune and more
8/25/2014 8:14:00 AM - Market Intelligence Center


Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha


Eli Lilly Uncovers Positive Data from Ixekizumab Studies - Analyst Blog
8/22/2014 4:45:00 PM - Zacks.com